BACKGROUND: We sought to determine the effect of peritoneal fluid from a novel animal model of abdominal compartment syndrome (ACS) on the proinflammatory status of polymorphonuclear leukocytes (PMNs) and monocytes. We hypothesize that peritoneal fluid is a potential priming and/or activating agent for PMNs/monocytes. METHODS: ACS was induced in female Yorkshire swine, and peritoneal fluid was collected at the time of decompressive laparotomy. Naïve PMNs/monocytes were primed and/or activated with peritoneal fluid, phosphatidylcholine (PAF) plus peritoneal fluid, peritoneal fluid plus n-formyl-met-leu-phe (fMLP), and peritoneal fluid plus phorbol 12-myristate 13-acetate (PMA). Activation was determined by surface marker expression of integrins (CD11b an CD18) and selectins (CD62L). Additionally, proinflammatory cytokines in peritoneal fluid were analyzed. RESULTS: Peritoneal fluid did not activate PMNs but increased CD11b expression on monocytes. When used as a primer for fMLP- or PMA-induced activation, peritoneal fluid significantly increased CD11b and CD18 expression on PMNs and monocytes. Peritoneal fluid collected at 6 and 12 h post decompressive laparotomy had similar effects. Interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) levels were increased in peritoneal fluid. CONCLUSION: Peritoneal fluid represents a primer for PMNs/monocytes and seems to act through receptor-dependent and receptor-independent pathways. Strategies to reduce the amount of peritoneal fluid may decrease the locoregional and systemic inflammatory response by reducing priming and activation of neutrophils/monocytes. Copyright 2010 Mosby, Inc. All rights reserved.
BACKGROUND: We sought to determine the effect of peritoneal fluid from a novel animal model of abdominal compartment syndrome (ACS) on the proinflammatory status of polymorphonuclear leukocytes (PMNs) and monocytes. We hypothesize that peritoneal fluid is a potential priming and/or activating agent for PMNs/monocytes. METHODS: ACS was induced in female Yorkshire swine, and peritoneal fluid was collected at the time of decompressive laparotomy. Naïve PMNs/monocytes were primed and/or activated with peritoneal fluid, phosphatidylcholine (PAF) plus peritoneal fluid, peritoneal fluid plus n-formyl-met-leu-phe (fMLP), and peritoneal fluid plus phorbol 12-myristate 13-acetate (PMA). Activation was determined by surface marker expression of integrins (CD11b an CD18) and selectins (CD62L). Additionally, proinflammatory cytokines in peritoneal fluid were analyzed. RESULTS: Peritoneal fluid did not activate PMNs but increased CD11b expression on monocytes. When used as a primer for fMLP- or PMA-induced activation, peritoneal fluid significantly increased CD11b and CD18 expression on PMNs and monocytes. Peritoneal fluid collected at 6 and 12 h post decompressive laparotomy had similar effects. Interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) levels were increased in peritoneal fluid. CONCLUSION: Peritoneal fluid represents a primer for PMNs/monocytes and seems to act through receptor-dependent and receptor-independent pathways. Strategies to reduce the amount of peritoneal fluid may decrease the locoregional and systemic inflammatory response by reducing priming and activation of neutrophils/monocytes. Copyright 2010 Mosby, Inc. All rights reserved.
Authors: Charles A Adams; Carl J Hauser; John M Adams; Zoltan Fekete; Da-Zhong Xu; Justin T Sambol; Edwin A Deitch Journal: Shock Date: 2002-12 Impact factor: 3.454
Authors: Zsolt Balogh; Bruce A McKinley; Charles S Cox; Steven J Allen; Christine S Cocanour; Rosemary A Kozar; Ernest E Moore; Charles C Miller III; Norman W Weisbrodt; Frederick A Moore Journal: Shock Date: 2003-12 Impact factor: 3.454
Authors: Shinil K Shah; Fernando Jimenez; Peter A Walker; Hasen Xue; Karen S Uray; Kevin R Aroom; Uwe M Fischer; Glen A Laine; Randolph H Stewart; Kenneth C Norbury; Charles S Cox Journal: J Trauma Date: 2010-03
Authors: Heitham T Hassoun; Uwe M Fischer; Bashir O Attuwaybi; Frederick A Moore; Hazim J Safi; Steven J Allen; Charles S Cox Journal: J Surg Res Date: 2003-11 Impact factor: 2.192
Authors: S K Shah; F Jimenez; P A Walker; H Xue; T D Feeley; K S Uray; K C Norbury; R H Stewart; G A Laine; C S Cox Journal: Eur J Trauma Emerg Surg Date: 2011-07-29 Impact factor: 3.693
Authors: Shinil K Shah; Fernando Jimenez; Peter A Walker; Hasen Xue; Teri D Feeley; Karen S Uray; Kenneth C Norbury; Randolph H Stewart; Glen A Laine; Charles S Cox Journal: Am J Surg Date: 2011-06-16 Impact factor: 2.565
Authors: Shinil K Shah; Fernando Jimenez; Phillip A Letourneau; Peter A Walker; Stacey D Moore-Olufemi; Randolph H Stewart; Glen A Laine; Charles S Cox Journal: Scand J Trauma Resusc Emerg Med Date: 2012-04-03 Impact factor: 2.953
Authors: Derek J Roberts; Craig N Jenne; Chad G Ball; Corina Tiruta; Caroline Léger; Zhengwen Xiao; Peter D Faris; Paul B McBeth; Christopher J Doig; Christine R Skinner; Stacy G Ruddell; Paul Kubes; Andrew W Kirkpatrick Journal: Trials Date: 2013-05-16 Impact factor: 2.279
Authors: Zhengwen Xiao; Crystal Wilson; Helen Lee Robertson; Derek J Roberts; Chad G Ball; Craig N Jenne; Andrew W Kirkpatrick Journal: Crit Care Date: 2015-10-27 Impact factor: 9.097